
Supriya Lifescience Ltd Sees Bullish Momentum Shift Amid Technical Upgrades
2026-08-06 08:06:01Supriya Lifescience Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Buy. The pharmaceutical and biotechnology company’s shares have gained 3.02% today, reflecting renewed investor confidence amid a broader positive technical trend.
Read full news article
Supriya Lifescience Ltd is Rated Buy
2026-08-05 10:10:03Supriya Lifescience Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of its performance and prospects.
Read full news article
Supriya Lifescience Ltd is Rated Buy by MarketsMOJO
2026-07-25 10:10:04Supriya Lifescience Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Supriya Lifescience Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-07-16 08:03:47Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-July 2026. Despite a recent day decline of 2.04%, the stock’s technical indicators, including MACD, RSI, and moving averages, suggest a cautiously optimistic outlook amid mixed signals across weekly and monthly timeframes.
Read full news article
Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-07-15 08:05:00Supriya Lifescience Ltd has demonstrated a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as MACD, moving averages, and Bollinger Bands, suggesting renewed investor interest and potential upside in the pharmaceuticals and biotechnology sector.
Read full news article
Supriya Lifescience Ltd is Rated Buy
2026-07-14 10:10:04Supriya Lifescience Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Supriya Lifescience Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-07-14 08:06:20Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-July 2026. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment amid the pharmaceuticals and biotechnology sector.
Read full news article
Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-07-09 08:06:39Supriya Lifescience Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. Following a recent upgrade from a Sell to a Buy rating, the pharmaceutical and biotechnology company is showing promising signs of price strength and positive market sentiment, supported by robust technical parameters and improving trend assessments.
Read full news article
Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-07-08 08:06:04Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a recent day decline of 2.78%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the latest technical parameters, price momentum, and market context to provide a comprehensive view for investors.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Supriya Lifescience Ltd has declared 50% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available






